$ATR

Gong Xiangwei sold $488K of ATR

Gong Xiangwei (President, Asia) sold 4,200 shares of APTARGROUP, INC. (ATR) at $116.13 ($0.49M total) on 2026-05-26.

Original reporting
SEC EDGAR · Gong Xiangwei
Published May 27, 2026, 7:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 7:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATR
Neutral
medium confidence
Mentioned
$ATR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATRNeutralLow
01

Why it matters

Because the disclosure contains only an officer’s sale details and no accompanying corporate catalyst, the market impact is likely sentiment-driven rather than fundamental.

02

Market read

Traders may briefly reassess sentiment around ATR due to insider selling, but the filing alone is unlikely to change valuation without additional news.

03

What to watch

No 10b5-1 plan is indicated; traders may overinterpret timing—compare with prior insider trades and total insider ownership trend.

Relevance 6/10Timing: Immediate (today’s filing) but event likely informationally weak.

Background

The article is an SEC Form 4 insider transaction disclosure (open-market sale) for AptarGroup, Inc. (ATR).

Company-level read

Ticker impact

$ATRNeutralMedium confidence
Context

SEC Form 4 shows ATR President, Asia Gong Xiangwei sold 4,200 shares for about $487,765 on 2026-05-26.

Expected impact

Likely limited/short-lived reaction; watch for follow-on insider activity or unusual volume.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan stated; however, it provides no new company-specific operational or financial information.

Market effects

No clear sector read-through from a single insider sale absent broader corporate news.

Minimal; transaction is company-specific and not tied to regional macro catalysts in the article.

Low; no international deal/regulatory/earnings linkage mentioned.

Counterpoint

The sale could be for diversification or personal liquidity rather than a negative view on ATR’s prospects.

Key entities

  • AptarGroup, Inc.

    ATR; officer Gong Xiangwei reported an open-market sale of 4,200 shares on 2026-05-26.

  • Gong Xiangwei

    President, Asia; sold $487,764.90 worth of ATR shares; holdings after sale: 10,774 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATRMed

Publication of a Circular

Schroder Asian Total Return Investment Company plc (ATR) said it has published a circular for shareholders on a proposed combination with Pacific Assets Trust plc (PAC). The plan would use a scheme of reconstruction and PAC’s members’ voluntary winding-up, transferring most PAC assets and issuing New ATR shares. A cash option is capped at 25% with a 2% discount; shareholder approval is required.

$ATRMedAI 8/10

Aptar (ATR) Q2 2026 Earnings Call Transcript

AptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.

$ATRMed

APTARGROUP, INC. (ATR): Results of Operations and Financial Condition

APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Aptar Reports Second Quarter 2026 Results Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results